Pages that link to "Item:Q1783524"
From MaRDI portal
The following pages link to Modelling HIV/AIDS in the presence of an HIV testing and screening campaign (Q1783524):
Displaying 25 items.
- Modeling HIV: determining the factors affecting the racial disparity in the prevalence of infected women (Q260848) (← links)
- Practical aspects of backward bifurcation in a mathematical model for tuberculosis (Q304655) (← links)
- Impact of early treatment programs on HIV epidemics: an immunity-based mathematical model (Q328854) (← links)
- Modelling hospitalization, home-based care, and individual withdrawal for people living with HIV/AIDS in high prevalence settings (Q417287) (← links)
- Modelling the HIV/AIDS epidemic trends in South Africa: insights from a simple mathematical model (Q546163) (← links)
- An age-structured model for the potential impact of generalized access to antiretrovirals on the South African HIV epidemic (Q611115) (← links)
- The dynamics of an HIV/AIDS model with screened disease carriers (Q634425) (← links)
- Modeling the effect of screening of unaware infectives on the spread of HIV infection (Q879589) (← links)
- An epidemic patchy model with entry-exit screening (Q887128) (← links)
- A model of HIV/AIDS population dynamics including ARV treatment and pre-exposure prophylaxis (Q1711233) (← links)
- Modeling saturated diagnosis and vaccination in reducing HIV/AIDS infection (Q1724076) (← links)
- The impact of pre-exposure prophylaxis (PrEP) and screening on the dynamics of HIV (Q1748176) (← links)
- Modelling the trend of HIV transmission and treatment in Kenya (Q1794712) (← links)
- Modeling the impact of random screening and contact tracing in reducing the spread of HIV. (Q1867866) (← links)
- A model for HIV in Asia (Q1901149) (← links)
- HIV/AIDS model with early detection and treatment (Q1954344) (← links)
- Mathematical modelling of the potential role of supplementary feeding for people living with HIV/AIDS (Q2001821) (← links)
- A comparative study between two systems with and without awareness in controlling HIV/AIDS (Q2011905) (← links)
- New numerical simulations for some real world problems with Atangana-Baleanu fractional derivative (Q2122304) (← links)
- Impact of Tenofovir gel as a PrEP on HIV infection: a mathematical model (Q2632627) (← links)
- On the future of HIV/AIDS in Botswana in the presence of drop-outs: insights from a simple mathematical model (Q2657606) (← links)
- HIV/AIDS MODEL FOR ASSESSING THE EFFECTS OF PROPHYLACTIC STERILIZING VACCINES, CONDOMS AND TREATMENT WITH AMELIORATION (Q3445553) (← links)
- Use of discrete-event simulation to evaluate strategies for the prevention of mother-to-child transmission of HIV in developing countries (Q4678261) (← links)
- A stochastic model for HIV with the use of PrEP (Q5080077) (← links)
- Mathematical modelling of the impact of testing, treatment and control of HIV transmission in Kenya (Q5193260) (← links)